Cristina Saura Manich MD, PhD

Cristina Saura has participated as Principal Investigator and Co-Investigator in multiple clinical trials in the field of breast cancer. Cristina Saura is currently involved in the development of different international studies with drugs directed against molecular targets in breast cancer. Cristina Saura has a special interest in Precision Medicine and a prominent position in the development of different PI3K inhibitors and anti-HER2 treatments. Cristina Saura is the author of several publications, as well as communications at different national and international congresses.

Dr. Saura graduated in Medicine from the University of Barcelona (UB) in 2002. From 2003 to 2007 she completed her internship in Medical Oncology at Vall d’Hebron University Hospital in Barcelona.

In 2007, dr. Saura obtained her Master of Advanced Studies with the project “Breast Cancer Early Detection Program in High-Risk Women: pilot breast mammography and breast magnetic resonance imaging tracking experience”, with an outstanding grade of “A”. Her interest in clinical research led her to complete the Program in Clinical Effectiveness at Harvard School of Public Health in Boston in 2007. She subsequently earned her Ph.D. in Medicine from the University Autonoma of Barcelona (UAB) in 2017 with honors cum laude with the project entitled “Treatment of breast cancer diagnosed during pregnancy”.